ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 92 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 6.67 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,695,000 | -16.1% | 601,515 | 0.0% | 0.23% | +58.3% |
| Q1 2022 | $3,212,000 | -63.7% | 601,515 | 0.0% | 0.14% | -42.2% |
| Q4 2021 | $8,842,000 | -29.7% | 601,515 | 0.0% | 0.25% | -20.4% |
| Q3 2021 | $12,578,000 | +18.2% | 601,515 | 0.0% | 0.31% | +15.9% |
| Q2 2021 | $10,641,000 | -27.8% | 601,515 | 0.0% | 0.27% | -38.5% |
| Q1 2021 | $14,737,000 | -27.6% | 601,515 | 0.0% | 0.44% | -27.2% |
| Q4 2020 | $20,361,000 | +223.7% | 601,515 | +139.2% | 0.60% | +113.8% |
| Q3 2020 | $6,290,000 | -25.9% | 251,515 | 0.0% | 0.28% | -43.8% |
| Q2 2020 | $8,484,000 | – | 251,515 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $99,703,000 | 11.34% |
| Euclidean Capital LLC | 777,193 | $16,251,000 | 7.90% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $12,594,000 | 7.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $21,068,000 | 5.64% |
| EcoR1 Capital, LLC | 3,468,944 | $72,536,000 | 2.52% |
| EMERALD ADVISERS, LLC | 726,236 | $15,186,000 | 0.55% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 742,666 | $15,529,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $48,879,000 | 0.54% |
| Casdin Capital, LLC | 601,515 | $12,578,000 | 0.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 53,000 | $1,104,000 | 0.27% |